CareLit Fachartikel
Absence of mutations in the HBsAg “a” determinant during REP 2139 therapy validates serum HBsAg reductions observed in the REP 102 protocol
Z Usman, H Mijočević, H Karimzadeh, M Al-Mahtab, M Bazinet, D Frishman, A Vaillant, M Roggendorf · Zeitschrift für Gastroenterologie · 2019 · Heft 01
Dokument
1193863
CareLit-ID
Jahr
2019
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig
Bibliografische Angaben
Zusammenfassung
Absence of mutations in the HBsAg “a” determinant during REP 2139 therapy validates serum HBsAg reductions observed in the REP 102 protocol
Schlagworte
Hbsag
Absence
Mutations
Determinant
During
Therapy
Validates
Serum
Reductions
Observed
Protocol
Zeitschrift für Gastroenterologie